Abstract
In this review, we analyzed the status and changes in the research on second-generation (atypical) antipsychotic drugs in the Asia-Pacific region (i.e., Japan, South Korea, Taiwan, Hong Kong, Singapore, and Australia). We also performed a bibliometric study of the literature in this region on atypical antipsychotic drugs (e.g., clozapine, risperidone, olanzapine, ziprasidone, quetiapine, sertindole, aripiprazole, paliperidone, amisulpride, zotepine, asenapine, iloperidone, lurasidone, perospirone, and blonanserin). We applied bibliometric indicators of production and dispersion (i.e., Price's law on the increase of scientific literature and Bradford's law, respectively). We also calculated the participation index of different countries. The data were also correlated with relevant social and health data from the Asia-Pacific region (e.g., the per capita gross domestic product and total per capita expenditure on health and gross domestic expenditure on research and development). All data are discussed together. We also analyzed the different aspects among the six countries in the region.
Original language | English |
---|---|
Pages (from-to) | 111-117 |
Number of pages | 7 |
Journal | Journal of Experimental and Clinical Medicine |
Volume | 6 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2014 |
Fingerprint
Keywords
- Atypical antipsychotic drug
- Bipolar disorder
- Risperidone
- Schizophrenia
ASJC Scopus subject areas
- Medicine(all)
Cite this
A Bibliometric Study on Second-generation Antipsychotic Drugs in the Asia-Pacific Region. / López-Muñoz, Francisco; Shen, Winston W.; Shinfuku, Naotaka; Pae, Chi Un; Castle, David J.; Chung, Albert K.; Sim, Kang; Álamo, Cecilio.
In: Journal of Experimental and Clinical Medicine, Vol. 6, No. 4, 2014, p. 111-117.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - A Bibliometric Study on Second-generation Antipsychotic Drugs in the Asia-Pacific Region
AU - López-Muñoz, Francisco
AU - Shen, Winston W.
AU - Shinfuku, Naotaka
AU - Pae, Chi Un
AU - Castle, David J.
AU - Chung, Albert K.
AU - Sim, Kang
AU - Álamo, Cecilio
PY - 2014
Y1 - 2014
N2 - In this review, we analyzed the status and changes in the research on second-generation (atypical) antipsychotic drugs in the Asia-Pacific region (i.e., Japan, South Korea, Taiwan, Hong Kong, Singapore, and Australia). We also performed a bibliometric study of the literature in this region on atypical antipsychotic drugs (e.g., clozapine, risperidone, olanzapine, ziprasidone, quetiapine, sertindole, aripiprazole, paliperidone, amisulpride, zotepine, asenapine, iloperidone, lurasidone, perospirone, and blonanserin). We applied bibliometric indicators of production and dispersion (i.e., Price's law on the increase of scientific literature and Bradford's law, respectively). We also calculated the participation index of different countries. The data were also correlated with relevant social and health data from the Asia-Pacific region (e.g., the per capita gross domestic product and total per capita expenditure on health and gross domestic expenditure on research and development). All data are discussed together. We also analyzed the different aspects among the six countries in the region.
AB - In this review, we analyzed the status and changes in the research on second-generation (atypical) antipsychotic drugs in the Asia-Pacific region (i.e., Japan, South Korea, Taiwan, Hong Kong, Singapore, and Australia). We also performed a bibliometric study of the literature in this region on atypical antipsychotic drugs (e.g., clozapine, risperidone, olanzapine, ziprasidone, quetiapine, sertindole, aripiprazole, paliperidone, amisulpride, zotepine, asenapine, iloperidone, lurasidone, perospirone, and blonanserin). We applied bibliometric indicators of production and dispersion (i.e., Price's law on the increase of scientific literature and Bradford's law, respectively). We also calculated the participation index of different countries. The data were also correlated with relevant social and health data from the Asia-Pacific region (e.g., the per capita gross domestic product and total per capita expenditure on health and gross domestic expenditure on research and development). All data are discussed together. We also analyzed the different aspects among the six countries in the region.
KW - Atypical antipsychotic drug
KW - Bipolar disorder
KW - Risperidone
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=84905733406&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905733406&partnerID=8YFLogxK
U2 - 10.1016/j.jecm.2014.06.001
DO - 10.1016/j.jecm.2014.06.001
M3 - Review article
AN - SCOPUS:84905733406
VL - 6
SP - 111
EP - 117
JO - Journal of Experimental and Clinical Medicine
JF - Journal of Experimental and Clinical Medicine
SN - 1878-3317
IS - 4
ER -